HOME >> MEDICINE >> NEWS
Physicians Study Whether "Super-Aspirin" Prevents Alzheimer's

Doctors at the University of Rochester and 39 other medical centers around the nation have begun a research study to see if a drug known as a super-aspirin -- an investigational compound made possible in part by basic medical research during the last decade at the university -- helps prevent Alzheimer's disease.

Twenty Rochester-area patients will be part of a group of about 1,300 people nationwide who will be treated with the experimental drug, which is similar to ibuprofen, naproxen, aspirin, and other painkillers, but appears to be safer and much more efficient at squelching pain and inflammation. The first of the drugs is currently being reviewed for the treatment of arthritis and may be available next year.

The drugs target cycloxygenase-2 or cox-2, an enzyme in the body first discovered and cloned by a University team led by Don Young and Kerry O'Banion. Scientists believe the enzyme is at the root of the pain and inflammation we feel from a variety of ailments, including arthritis. Existing painkillers like ibuprofen and aspirin inhibit both cox-2 and cox-1, a closely related enzyme. For years physicians believed that knocking out cox-1 helped patients feel better, but now most doctors believe that cox-2 is the real pain-causing culprit in many illnesses. Currently drugs targeting cox-2 are being tested as a way to treat arthritis more aggressively with fewer side effects, and they're being looked at as a possible way to prevent colon cancer.

This study is one of the first to see whether such drugs might prevent or delay Alzheimer's disease. During the past few years, O'Banion and others have discovered that cox-2 is active in the brains of people who have the disease. Though the precise cause of Alzheimer's disease is still a mystery, scientists believe the enzyme plays some role in the sickness and death of brain cells of patients. Since cox-2 inhibitors muck up the enzyme's activity, they might help protect the brain agains
'"/>

Contact: Tom Rickey
trickey@admin.rochester.edu
716-275-7954
University of Rochester
19-Nov-1998


Page: 1 2

Related medicine news :

1. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
2. Physicians call for increased funding for federal infectious disease programs
3. Physicians response to religion-related conflicts in medicine
4. Physicians may need to dig deeper when treating HIV-related lymphomas
5. American College of Chest Physicians announces new Critical Care Institute
6. Chronic care medicine: Physicians say help!
7. Physicians have mixed opinions about consumer-targeted pharmaceutical ads
8. Physicians, patients must work together on new electronic relationships
9. Physicians can help family members caring for dying loved ones
10. American College of Chest Physicians to offer developing nations free access to medical journal
11. Physicians and patients rarely discuss costs

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Physicians Study Whether Super Aspirin Prevents Alzheimer

(Date:6/19/2013)... As warmer weather arrives and vacations begin, Asheville’s ... summertime packages. , “Whether guests are traveling to Asheville ... staycation, we think that these available packages will offer ... so beautiful in the summertime and there is a ... can choose from, based on their interests, offers something ...
(Date:6/19/2013)... 2013 According to Fastcare ... sun exposure is perhaps the biggest and certainly ... that is just one of many potential factors ... cancer. Other risk factors include:, , ... ,     Heredity may play a role , ...
(Date:6/19/2013)... The benefits, NASS said, ... the overall experience for the majority of those who ... Mr Mouw, whose Virgina-based company enjoys an international clientele, ... saying that the type of sauna is also important. ... counterfeit imitations which frankly, can be extremely dangerous particularly ...
(Date:6/19/2013)... Hollywood, CA (PRWEB) June 19, 2013 ... conditions with little to no access to the medical ... organizations are providing access to health care and the ... of these third-world nations. , Outlook with ... organizations to reveal the conditions in which these people ...
(Date:6/19/2013)... 19, 2013 Daily Gossip issued a press ... method will be published on their website at the ... article to inform readers about the information they will find ... reporters working at Daily Gossip, the article is a review ... , Hiller has understood during the vast research he has ...
Breaking Medicine News(10 mins):Health News:Fun Depot Partners with Brookstone Lodge on Summer Packages 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 3Health News:Health Benefits of Saunas Only Viable with Properly Constructed Models, Warns Manufacturer 2Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2
(Date:6/19/2013)... Calif. , June 19, 2013 Pharmacyclics, ... announced that The New England Journal of Medicine ... 2 study evaluating the investigational oral Bruton,s tyrosine kinase ... lymphoma (MCL) online. These data suggested ibrutinib may be ... Results of a separate study examining ...
(Date:6/19/2013)...  Haemonetics Corporation (NYSE: HAE ) ... of its previously announced manufacturing transformation.  ... , Haemonetics has selected Sanmina Corporation (NASDAQ: ... medical devices currently manufactured in Braintree ... of integrated manufacturing solutions, components, products and repair, ...
(Date:6/19/2013)... YORK , June 19, 2013 /PRNewswire-iReach/ -- ... pioneer of modern hair transplant procedures and founder ... was included in the ,Best Doctors, issue of ... (Photo:  http://photos.prnewswire.com/prnh/20130619/CG34629 ) ... Best Doctors issue, and his reputation as world-renowned ...
Breaking Medicine Technology:Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 2Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 4Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 5Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 6Haemonetics Announces Next Steps in Manufacturing Transformation 2Haemonetics Announces Next Steps in Manufacturing Transformation 3Haemonetics Announces Next Steps in Manufacturing Transformation 4Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 2Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 3
Cached News: